Trials / Completed
CompletedNCT02621320
Vitamin D Supplementation in Wheelchair Indoor Athletes
Effect of Vitamin D3 Supplementation on Exercise Performance in Wheelchair Athletes.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Swiss Paraplegic Research, Nottwil · Network
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
There is a high prevalence of vitamin D deficiency in Switzerland. In indoor-athletes as well as wheelchair users, vitamin D deficiency occurs even more often. It is well established that vitamin D deficiency has a negative effect on health. However, vitamin D supplementation in individuals with a vitamin D deficiency has a positive effect on muscle performance. In recently published studies with able-bodied subjects, it has been shown that a normal vitamin D level (\>75nmol/L) can only be achieved with a high-dose supplementation of vitamin D. The aim of this study is to examine the effect of vitamin D supplementation on exercise performance in wheelchair athletes with vitamin D deficiency . All participants with a vitamin D deficiency are assigned to the intervention group and treated with 6000 IU of vitamin D3 daily over a period of 12 weeks. All participants who have a normal vitamin D level will receive placebo treatment (control group). The physical performance is measured three times at baseline, after six weeks and 12 weeks. The measurements include a Wingate and a dynamometer test.
Conditions
- Vitamin D Deficiency
- Spinal Cord Injury
- Drug Effects
- Dietary Supplements
- Physical Education and Training/Methods
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin D | Vitamin D3 (Vi-De 3®. WILD) 6000IU daily over a period of 12 weeks. |
| DIETARY_SUPPLEMENT | Placebo | alcohol-based solution 1.3ml daily over a period of 12 weeks. |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-07-01
- Completion
- 2016-08-01
- First posted
- 2015-12-03
- Last updated
- 2016-11-22
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02621320. Inclusion in this directory is not an endorsement.